Notícias Prime Medicine Inc - PRME | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Prime Medicine Inc (PRME)
Prime Medicine Inc (PRME) Notícias

Prime Medicine Inc (PRME)

2,84

0,245

(9,44%)

Fechado 17 Fevereiro 6:00PM

Atrasado por 15 minutos

2,85

0,01

(0,35%)

Após o horário de negociação: 8:00PM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Form 8-K - Current report

Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

Prime Medicine to Participate in Upcoming Investor Conferences

Form 8-K - Current report

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

Form 8-K - Current report

Prime Medicine Unveils Strategically Focused Pipeline

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Exchange Traded

Viveon Health Acquisition (CE)

Van de Velde NV (PK)

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições